Projects
-
RP1 - Reinartz/Worzfeld Influence of tumor-host secretome on ovarian cancer cell invasion and metastasis
-
RP2 - Huber/Müller Intercellular signaling mediated by pro-inflammatory IL17A/F in ovarian cancer
-
RP3 - Pogge von Strandmann The role of HSP70-positive extracellular vesicles from tumor cells for the function of macrophages and NK cells within the ovarian cancer microenvironment
-
RP4 - Schmitz Characterization and selective targeting of deregulated NF-κB activation pathways in ovarian cancer cells
-
RP5 - Kracht The role of CDK - NF-κB crosstalk in shaping de novo protein synthesis, shedding and secretion of inflammatory mediators
-
RP6 - Stiewe Remodeling of the tumor microenvironment by mutant p53-stimulated glycoprotein secretion
-
RP7 - Liefke/Neubauer Overcoming AML drug resistance by attacking SKI and the PRC2/NF-κB-axis
-
RP8 - Burchert Secretome analysis to elucidate the mechanism of the sorafenib response and treatment therapy failure in transplanted FLT3-ITD AML patients
-
RP9 - Gómez-Serrano Elucidating the adipocyte-tumour cell crosstalk via extracellular vesicles in the context of the ovarian cancer tumor microenvironment
-
RP 10 - Dr. Johannes Mayer Dendritic cell reprogramming through the tumor secretome leads to dysfunctional anti-tumor T cell responses